National Early Warning Score 2 (Hypercapnic)

For patients WITH hypercapnic respiratory failure

NEWS2 (hypercapnic) is the modified NEWS2 that uses an SpO2 scale targeting 88–92% to safely score patients with hypercapnic respiratory failure (via the adjusted saturation scale in NICE/RCPE guidance 1 [Level I evidence]).

SpO2% (Hypercapnic)
88-92%093% or higher on room air086-87%+193-94% on supplemental O2+184-85%+295-96% on supplemental O2+283% or less+397% or higher on supplemental O2+3
Supplemental O2?
No0Yes+2
Respiratory Rate (breaths/min)?
12-2009-11+121-24+28 or less+325 or more+3
SBP? (mmHg)
111-2190101-110+191-100+290 or less+3
Heart Rate (beats/min)
51-100041-50+1101-110+1Less than 40+2111-129+2130 or faster+3
Temperature?
36.1-38.0C (96.9-100.4F)035.1-36.0C (95.1-96.8F)+138.1-39.0C (100.5-102.2F)+139.1C or higher (102.3F)+235.0C or less (95.0F)+3
Mental Status?
Alert0New-onset mental status alteration (responds to voice, pain, or unresponsive)+3

Indicações de Uso

Used for adults with suspected clinical deterioration who have chronic or acute-on-chronic hypercapnic respiratory failure, applying SpO2 Scale 2 (target 88–92%) to avoid hyperoxia‑induced CO2 retention. Supports early detection of sepsis or respiratory decompensation and guides escalation frequency (0–4 low, 5–6 moderate, ≥7 high risk) per NICE sepsis guidance 1. Enables repeat monitoring to assess response and trigger timely senior review.

Insights e Precauções

Use of this hypercapnic-adjusted score helps avoid inappropriate downgrading when target SpO2 is 88–92% in chronic hypercapnia, improving sensitivity over the original version, particularly in COPD cohorts where NEWS2 performed better than NEWS (AUROC 0.72 vs 0.65) 1 [Level II evidence]. Caution: predictive accuracy remains moderate, false triggers are common, and clinical judgment is essential; performance varies across respiratory populations 2 [Level III evidence].